Диссертация (1139906), страница 24
Текст из файла (страница 24)
– 2004. – Vol.113(2). –P.186-90.114.Ladyman S.R., Augustine R.A., Grattan D.R. Hormone interactions regulatingenergy balance during pregnancy // J Neuroendocrinol. – 2010. – Vol.22(7). – P.805-17.115.Lager S., Powell T.L. Regulation of nutrient transport across the placenta // JPregnancy. – 2012. - 2012:179827.116.Linask K.K., Han M., Bravo-Valenzuela N.J. Changes in vitelline andutero-placental hemodynamics: implications for cardiovascular development // FrontPhysiol.
– 2014. – Vol.11. – P.390.117.Longtine M.S., Nelson D.M. Placental dysfunction and fetal programming: theimportance of placental size, shape, histopathology, and molecular composition //Semin Reprod Med. – 2011. – Vol.29(3). – P. 187–196.118.Maconochie N., Doyle P., Prior S. Risk factors for first trimester miscarriage –results from a UK-population-based case–control study // BJOG.
– 2007. – Vol.114. –P.170–186.119.Maheshwari A., Kalampokas T., Davidson J. Obstetric and perinatal outcomesin singleton pregnancies resulting from the transfer of blastocyst-stage versuscleavage-stage embryos generated through in vitro fertilization treatment: a systematicreview and meta-analysis // Fertil Steril.
– 2013. – Vol.100(6). – P.1615-21.120.Miesnik S.R., Reale B.J. A review of issues surrounding medically electivecesarean delivery // JOGNN. – 2007. – Vol.36. – P.605–615.121.Mifsud W., Sebire N.J. Placental pathology in early-onset and late-onset fetalgrowth restriction // Fetal Diagn Ther.
– 2014. – Vol.36(2). – P.117-28.122.Mihu C.M., Suşman S., Rus Ciucă D. et al. Aspects of placental morphogenesisand angiogenesis // Rom J Morphol Embryol. - 2009. – Vol.50(4). – P. 549-57.123.Minkoff H.L., Berkowitz R. The myth of the precious baby // Obstetrics andGynecology. – 2005. – Vol.106. – P.607–609.124.Moran M., McAuliffe F.M. Imaging and assessment of placental function // JClin Ultrasound. – 2011. – Vol.39(7).
– P.390-8.125.Murthi P., Kalionis B., Rajaraman G. et al. The role of homeobox genes in thedevelopment of placental insufficiency // Fetal Diagn Ther. – 2012. – Vol.32(4). –P.225-30.126.Newbern D., Freemark M. Placental hormones and the control of maternalmetabolism and fetal growth // Curr Opin Endocrinol Diabetes Obes. – 2011. –Vol.18(6). – P. 409-16.127.Noguchi J, Hata K, Tanaka H et al. Placental vascular sonobiopsy usingthree-dimensional power Doppler ultrasound in normal and growth-restricted fetuses //Placenta. -2009. – Vol.30(5).
– P. 391–7.128.Ombelet W., Cadron I., Gerris J. Obstetric and perinatal outcome of 1655 ICSIand 3974 IVF singleton and 1102 ICSI and 2901 IVF twin births: a comparativeanalysis // Reprod Biomed Online. – 2005. – Vol.11(1). – P.76-85.129.Oyelese Y. Placenta, umbilical cord and amniotic fluid: the not-less-importantaccessories // Clin Obstet Gynecol. – 2012. – Vol.55(1). – P.307-23.130.Papageorghiou A.T., Yu C.K., Bindra R. et al Medicine Foundation SecondTrimester Screening Group Multicenter screening for preeclampsia and fetal growthrestriction by transvaginal uterine artery Doppler at 23 weeks of gestation // UltrasoundObstet Gynecol. – 2001.
– Vol.18. – P.441–449.131.Papageorghiou A.T., Yu C.K., Cicero S. Second-trimester uterine artery Dopplerscreening inunselected populations: a review // J Matern Fetal Neonatal Med. – 2002. –Vol.12. – P.78–88.132.Phelan J.P. Amniotic fluid index assessment with four-quadrant technique at36-42 weeks gestation/ J.P. Phelan, C.V. Smith, P. Broussart et al. // J. Reprod. Med.1987.- V.32.- P.540-542.133.Plowden T.C., Novak C.M., Spong C.Y. Disparities in obstetrical outcomes inART pregnancies compared with natural conceptions // Semin Reprod Med.
– 2013. –Vol.31(5). – P.340-6.134.Pourcelot L. Applications cliniques de lexamen doppler transcutane / L.Pourcelot // Velocimetre Ultrasonore Doppler. Ed. By P. peronneau. Paris : Vigot. 1975.- P.159-163.135.Rai A., Cross J.C. Development of the hemochorial maternal vascular spaces inthe placenta through endothelial and vasculogenic mimicry // Dev Biol. – 2014. –Vol.387(2). – P.131-41.136.Rampersad R., Cervar-Zivkovic M.N.Development and Anatomy of theHuman Placenta // The placenta: From development to disease /Ed.
By Helen H/ Kay etal. – Wiley-Blackwell. –2011.- Chap.3. – p.19-27.137.Redman CW.G., Sargent I.L., Roberts J.M. Immunology of normal pregnancyand preeclampsia // Elsevier. – 2009. – Vol. 34(23). – P. 129–144.138.Rizzo G., Capponi A., Pietrolucci M.E. et al. First trimester placental volumeand vascularization measured by 3-dimensional power Doppler sonography inpregnancies with low serum pregnancy-associated plasma protein a levels // Journal ofUltrasound in Medicine. – 2009.
– Vol.28(12). – P.1615–22.139.Royal College of Obstetricians and Gynaecologists. Small-for-gestational-agefetus, investigation and management (Green-top Guideline No. 31). London: RCOG;2013.140.Savasan Z.A., Goncalves L.F., Bahado-Singh R.O. Second- and third-trimesterbiochemical and ultrasound markers predictive of ischemic placental disease // SeminPerinatol. – 2014.
– Vol.38(3). – P.167-76.141.Sazonova A., Källen K., Thurin-Kjellberg A. Factors affecting obstetric outcomeof singletons born after IVF // Hum Reprod. – 2011. – Vol.26(10). – P.2878-86142.Serman A., Serman L. Development of placenta in a rodent--model for humanplacentation // Front Biosci (Elite Ed). – 2011. – Vol.3. – P.233-9.143.Shepard M.J.
A standartized planefor biparietal diameter measurement / M.J.Shepard, R.A. Filly // J. Ultrasound. Med. - 1982.- V.1. - P.145-149.144.Shwarzman P., Waintraub A.Y., Frieger M. Third-trimester abnormal uterineartery Doppler findings areassociated with adverse pregnancy outcomes // J UltrasoundMed. – 2013. – Vol.32. – P.2107–2113.145.Soares M.J.
The prolactin and growth hormone families: Pregnancy-specifichormones/cytokines at the maternal-fetal interface / M.J. Soares // ReproductiveBiology and Endocrinology. ‒ 2004. ‒ № 2. ‒ Р. 51.146.Society of Obstetricians and Gynaecologists of Canada, Okun N, Sierra S.Pregnancy outcomes after assisted human reproduction // J Obstet Gynaecol Can. –2014.
– Vol.36(1). – P.64-83.147.Spong C.Y. Prevention of the First Cesarean Delivery // Obstet Gynecol ClinNorth Am. – 2015. – Vol.42(2). – P.377-380.148.Stojnic J., Radunovic N., Jeremic K. Perinatal outcome of singleton pregnanciesfollowing in vitro fertilization // Clin Exp Obstet Gynecol. – 2013. – Vol.40(2). –P.277-83.149.Sullivan E.A., Chapman M.G., Wang Y.A. Population-based study of cesareansection after in vitro fertilization in Australia // Birth.
– 2010. – Vol.37(3). – P.184–191.150.Tietz Clinical guide to laboratory tests. 4-th ed. Ed. Wu A.N.B. - USA,W.BSounders Company. – 2006. – P. 156.151.Thomopoulos C., Tsioufis C., Michalopoulou H. Assisted reproductivetechnology and pregnancy-related hypertensive complications: a systematic review // JHum Hypertens.
– 2013. – Vol.27(3). – P.148-57.152.Tita T.N., Landon M.B., Spong C.Y. et al. Timing of elective repeat cesareandelivery at term and neonatal outcomes // The New England Journal ofMedicine. – 2009.– Vol.360. – P.111–120.153.Toal M., Chaddha V., Windrim R. Ultrasound detection of placentalinsufficiency in women with elevated second trimester serum alpha-fetoprotein orhuman chorionic gonadotropin // J Obstet Gynaecol Can. – 2008. – Vol.30(3). –P.198-206.154.Todros T., Piccoli E., Rolfo A.
Review: Feto-placental vascularization: amultifaceted approach // Placenta. – 2011. – Vol.32. – P.165-9.155.Trogstad L., Magnus P., Stoltenberg C. Pre-eclampsia: Risk factors and causalmodels // Best Pract Res Clin Obstet Gynaecol. – 2011. – Vol.25(3). – P. 329-42.156.Turan S., Turan O.M., Berg C. Moyano D, Bhide A, Bower S, et al.Computerized fetal heart rate analysis, Doppler ultrasound and biophysical profile scorein the prediction of acidebase status of growth-restricted fetuses // Ultrasound ObstetGynecol.
– 2007. – Vol.30. – P.750.157.Tuuli M.G., Odibo A.O. Ultrasound Imaging and Doppler. Studies of thePlacenta // The placenta: From development to disease /Ed. By Helen H/ Kay et al. –Wiley-Blackwell. – Chap.16. – P.122-131.158.Velauthar L., Plana M.N., Kalidindi M. et al. Uterine artery Doppler in the firsttrimester as a risk factor for adverse pregnancy outcomes: a meta-analysis involving55,974 women // Ultrasound Obstet Gynecol. - 2013.-Р.500-507.159.Viero S., Chadda V., Alkazaleh F.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
